Search Results

By integrating advanced tools and translational biology, his work directly informs therapeutic strategies

Sep 20, 2022 — First contributor article published: Therapeutic validation of an orphan G protein‐coupled

a Ph.D. degree in 2003 with a particular interest in the cardiovascular system by investigating the structure

I help CRO teams bring structure to collaboration—so your data gets acted on, not overlooked.

I bring structure, decision frameworks, and momentum so your team stays on track.

Explore the Masterclass On Demand Watch Now Structure-Based Design of Modulators of Purinergic GPCRs University helps you understand and apply that knowledge — through expert context, structured scientific

analysis, revealed nuanced roles of RGS4, RGS9, and RGSZ — not just as modulators but as potential therapeutic

She developed expertise over the past two decades studying structure/function relationships of GPCRs

The program will include also world-class and diverse GPCR scientists working in the arenas of structure

Jacobson, Matteo Pavan Structure-Based Design of Modulators of Purinergic GPCRs Terry Kenakin Assessing

She developed expertise over the past two decades studying structure/function relationships of GPCRs

University helps you understand and apply that knowledge — through expert context, structured scientific

Whether you’re decoding signaling pathways or designing the next generation of therapeutics, Revvity

mutation paradigm 25:05 AI, in silico screening, and the limits of computational drug discovery without structures

If you’re working on exciting GPCR-related research — from structural biology to drug discovery — we’